// App-Quantinova.ai

1354 : Developing 384-well and 1536-well cell growth inhibition assay workflow for screening drug-drug combination in tumor cell lines

Researchers

Presenter

  • Yvonne Li

Principal Investigators

  • Mike Ma

  • Julie Chan

  • Yang Tian

  • Nikos Pagratis

  • Derek Stonich

  • Victor Chen

  • Louis Zhang

  • Mark Kenney

Medical Centers

  • Gilead Sciences, Inc., Foster City, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • DMSO

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A